Acute and chronic graft-versus-host disease in man.
D000208:Acute Disease; D000367:Age Factors; D016026:Bone Marrow Transplantation; D002908:Chronic Disease; D003524:Cyclosporins / Q000494:pharmacology; D004359:Drug Therapy, Combination / Q000379:methods; D006086:Graft vs Host Disease / Q000453:epidemiology / Q000209:etiology / Q000276:immunology / Q000517:prevention & control / Q000628:therapy; D006680:HLA Antigens / Q000276:immunology; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects; D007165:Immunosuppression Therapy / Q000379:methods; D007239:Infections / Q000150:complications; D008727:Methotrexate / Q000494:pharmacology; D011239:Prednisolone / Q000494:pharmacology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000276:immunology
D003524:Cyclosporins; D006680:HLA Antigens; D011239:Prednisolone; D008727:Methotrexate